Navigation Links
Radiation After Surgery Lowers Chances of Breast Cancer's Return
Date:12/8/2010

TUESDAY, Dec. 7 (HealthDay News) -- Women with localized breast cancer are less likely to develop invasive cancer if they receive radiation after surgery, a new study finds.

The researchers also found that treatment with the drug tamoxifen greatly reduced the risk of the recurrence of localized cancer.

The three-nation study included patients with ductal carcinoma in situ (DCIS), the most common type of noninvasive breast cancer, who were followed for a median of 12.7 years.

The researchers found that radiation after surgery reduced the risk of invasive cancer in the same breast by nearly 70 percent and decreased recurrent DCIS in the same breast by more than 60 percent. Radiation therapy had no effect on the other breast.

"This study is very important in confirming the benefits of radiotherapy in the treatment of ductal carcinoma in situ and, most importantly, decreasing the incidence of invasive carcinoma developing in the same breast," said Dr. Lauren Cassell, chief of breast surgery at Lenox Hill Hospital in New York City. "If we could only identify which particular patients were most at risk, we could target our radiotherapy to those patients who truly benefit from it and avoid over-treating others."

The study also found that treatment with tamoxifen lowered the risk of cancer recurrence in the same breast by about 30 percent, and it decreased the risk of new cancer in the other breast by more than 65 percent.

The findings appear online Dec. 7 in The Lancet Oncology.

The findings confirm "the long-term beneficial effect of radiotherapy and reports a benefit for tamoxifen in reducing local and contralateral new breast events for women with DCIS treated by complete excision," study author Jack Cuzick, of Cancer Research U.K. and Queen Mary's School of Medicine and Dentistry in London, and colleagues wrote in a news release from the journal.

"This trial emphasizes the importance of radiotherapy in high-grade [more quickly growing and more likely to spread] DCIS and also suggests a role for tamoxifen, primarily for new contralateral disease," they concluded.

More information

The American Cancer Society has more about breast cancer.

-- Robert Preidt

SOURCES: The Lancet Oncology, news release, Dec. 7, 2010; Lauren Cassell, M.D., chief, breast surgery, Lenox Hill Hospital, New York City


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. FDA Seeks Reduction in Radiation From Medical Scans
2. For Some Breast Cancer Patients, Shorter Radiation Works Well
3. Short-term radiation therapy successful on breast cancer
4. ASCROs Response to NY Times Articles on Radiation Therapy Incidents
5. Imaging manufacturers: Plan to reduce unnecessary radiation exposure and medical errors
6. Roseville Radiation Oncology Center (ROC) Redefines Efficiency With Elekta VMAT Radiotherapy Treatments
7. New cardiac CT technology drastically reduces patient radiation exposure
8. New Heart CT Scans Deliver Far Less Radiation: Study
9. Accelerated radiation therapy reduces toxicity in patients with advanced head and neck cancers
10. Delaying post-surgical radiation increases risk of breast cancer recurrence in older women
11. Radiation Most Effective Soon After Breast Cancer Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Radiation After Surgery Lowers Chances of Breast Cancer's Return 
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), creator ... tool, and the Cancer Patient Education Network (CPEN), an independent professional organization that ... new strategic alliance. , As CPEN’s strategic partner, HLI will help support ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 ... ... Company, Cal Dining at the University of California Berkeley, and other leading institutions ... leverages the buying power of institutions to change the way animals are raised ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
Breaking Medicine Technology: